Top Markets
#1 ADO Protocol ADO Protocol +194.13%
#2 GoPlus Security GoPlus Security +39.05%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.18%
#5 Tutorial Tutorial +13.45%
#6 Verus Coin Verus Coin +13.11%
#7 o1.exchange o1.exchange +12.65%
#8 Pons Pons +12.63%
#9 SkyAI SkyAI +11.49%
#10 Status Status +11.24%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Clasificación en acciones #33954
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Precio por acción
$1.83
Última sincronización: 2026-08-14
Capitalización bursátil
$6.53M
Cambio (1 día)
-1.61%
Cambio (1 año)
-85.57%
País
US
Comercio Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Categoría

Healthcare
Historial del precio de la acción de Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Precio más alto de cierre: $1.89 el 2026-08-01

Precio más bajo de cierre: $46.78 el 2023-01-01
Historial del precio de la acción de Cadrenal Therapeutics, Inc. Common Stock desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE